# Humanplus Intelligent Robotics Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/humanplus-intelligent-robotics-technology-co

- Industry: Consumer Products
- Headquarters: Beijing, China
- Website: www.humanplus.cc
- Total disclosed funding: $4.6M
- Latest round: Series A (Jun 5, 2018)
- Investors on record: 5

## About

Humanplus Intelligent Robotics Technology Co., Ltd. focuses on innovative human augmentation technologies, enhancing physical capabilities through advanced wearable devices tailored for individuals with mobility challenges and healthcare providers.Founded in 2016 and headquartered in Beijing, China, Humanplus Intelligent Robotics Technology Co., Ltd. develops advanced wearable devices that enhance mobility for users. The company has secured a total of CNY 30.00 mn through a Series A funding round led by Zhongsai Capital, with participation from Zoy Capital, as of June 5, 2018. Jiajun Li serves as both the Founder and CEO, providing leadership in their strategic direction.Humanplus specializes in developing and deploying advanced human augmentation technologies. Their primary offerings include wearable devices that assist individuals with mobility challenges, enhancing independence in daily tasks. The products cater to consumers with disabilities, rehabilitation centers, and healthcare facilities, focusing on mobility enhancement, physical therapy support, and overall wellness. Since their initial product launch, Humanplus has expanded into North America and select markets in Europe, addressing a diverse clientele that includes healthcare professionals and fitness enthusiasts.Humanplus generates revenue mainly through direct-to-consumer sales and partnerships with healthcare providers, emphasizing the distribution of their flagship wearable technology. They operate on a subscription model, allowing clients access to a tiered pricing plan that includes maintenance, upgrades, and personalized support. Collaborations with rehabilitation facilities and wellness centers enable these organizations to integrate Humanplus products into their therapeutic offerings, with pricing determined by customer needs and device features.Looking ahead, Humanplus plans to launch new products aimed at enhancing their existing technology portfolio. They are focusing on expansion into additional international markets, specifically targeting regions in North America and Europe by 2025. The recent Series A funding round will be utilized to support these initiatives, enhancing product development and market reach. The company aims to strengthen its presence in these regions through strategic partnerships and localized marketing efforts.

## Funding rounds

- Series A, Jun 5, 2018 — Zoy Capital, Zhongsai Capital
- Seed, Nov 28, 2016 — DL Capitals, Zoy Capital, China Milestone Investment Management
- Series A, May 1, 2016, $4.6M — Zoy Capital, Zhongsai Capital
- Angel, Apr 1, 2016 — Grains Valley Venture Capital

## Investors

- Grains Valley Venture Capital (https://capitalatlas.ai/funds/grains-valley-venture-capital) — Angel
- Zoy Capital (https://capitalatlas.ai/funds/zoy-capital) — Series A, Seed
- Zhongsai Capital — Series A
- DL Capitals (https://capitalatlas.ai/funds/dl-capitals) — Seed
- China Milestone Investment Management — Seed